Stocks and Investing Stocks and Investing
Tue, September 29, 2020
Mon, September 28, 2020
Sat, September 26, 2020
Fri, September 25, 2020
Thu, September 24, 2020
Wed, September 23, 2020
Tue, September 22, 2020
Mon, September 21, 2020
Sun, September 20, 2020
Fri, September 18, 2020

Brian Abrahams Maintained (BIIB) at Hold with Decreased Target to $277 on, Sep 18th, 2020


Published on 2024-10-27 13:27:28 - WOPRAI, Brian Abrahams
  Print publication without navigation


Brian Abrahams of RBC Capital, Maintained "Biogen Inc." (BIIB) at Hold with Decreased Target from $284 to $277 on, Sep 18th, 2020.

Brian has made no other calls on BIIB in the last 4 months.



There are 5 other peers that have a rating on BIIB. Out of the 5 peers that are also analyzing BIIB, 2 agree with Brian's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Carter Gould of "Barclays" Downgraded from Buy to Hold and Decreased Target to $280 on, Monday, June 22nd, 2020
  • Aaron Gal of "Bernstein" Downgraded from Buy to Hold and Decreased Target to $297 on, Tuesday, June 9th, 2020


These are the ratings of the 3 analyists that currently disagree with Brian


  • Marc Goodman of "SVB Leerink" Maintained at Buy with Decreased Target to $342 on, Wednesday, August 19th, 2020
  • Matthew Harrison of "Morgan Stanley" Upgraded from Sell to Buy and Increased Target to $357 on, Monday, July 27th, 2020
  • Brian Skorney of "Baird" Maintained at Sell with Decreased Target to $228 on, Friday, June 19th, 2020